Methodology

All entries for: XORTX Therapeutics

March 19, 2026

XORTX Therapeutics

Neutral Outlook

Calgary, Canada
1-50 employees

The effect of Inflation Reduction Act of 2022 on our business and the pharmaceutical industry in general is not yet known.

Disease Area: Cardiovascular, Infectious Diseases, Rare Diseases
Drug Type: Small Molecule
Source
Source
Scroll to Top